| Literature DB >> 16557300 |
Sudarshan Anand1, Pu Wang, Kiyoshi Yoshimura, In-Hak Choi, Anja Hilliard, Youhai H Chen, Chyung-Ru Wang, Richard Schulick, Andrew S Flies, Dallas B Flies, Gefeng Zhu, Yanhui Xu, Drew M Pardoll, Lieping Chen, Koji Tamada.
Abstract
LIGHT is an important costimulatory molecule for T cell immunity. Recent studies have further implicated its role in innate immunity and inflammatory diseases, but its cellular and molecular mechanisms remain elusive. We report here that LIGHT is upregulated and functions as a proinflammatory cytokine in 2 independent experimental hepatitis models, induced by concanavalin A and Listeria monocytogenes. Molecular mutagenesis studies suggest that soluble LIGHT protein produced by cleavage from the cell membrane plays an important role in this effect through the interaction with the lymphotoxin-beta receptor (LTbetaR) but not herpes virus entry mediator. NK1.1+ T cells contribute to the production, but not the cleavage or effector functions, of soluble LIGHT. Importantly, treatment with a mAb that specifically interferes with the LIGHT-LTbetaR interaction protects mice from lethal hepatitis. Our studies thus identify a what we believe to be a novel function of soluble LIGHT in vivo and offer a potential target for therapeutic interventions in hepatic inflammatory diseases.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16557300 PMCID： PMC1409742 DOI： 10.1172/JCI27083
Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808